Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients
This study has been completed.
Study NCT00327288   Information provided by AmpliMed Corporation

First Received on May 17, 2006.   Last Updated on September 14, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Non-small Cell Lung Cancer
Breast Cancer
Prostate Cancer
Additional conditions recognized in this trial
Breast Neoplasms
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Prostatic Neoplasms
More general conditions related to this trial
Breast Diseases
Bronchial Neoplasms
Carcinoma, Bronchogenic
Genital Diseases, Male
Genital Neoplasms, Male
Lung Diseases
Neoplasms
Neoplasms by Site
Prostatic Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Skin Diseases
Thoracic Neoplasms
Urogenital Neoplasms
Interventions listed in this trial
imexon
docetaxel
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
AmpliMed Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services